Friday, January 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

NIH Clinical Center Seeks Decontamination Services for Drug-Resistant Bacteria

by Global Biodefense Staff
July 12, 2018
Environmental Decontamination in Medical Settings

The National Institutes of Health (NIH) Clinical Center Hospital Epidemiology Service (HES) is seeking vendor quotes for decontamination services of rooms and equipment that may be contaminated with multidrug-resistant bacteria.

The HES has identified infection or colonization with multidrug-resistant bacteria that have the potential to spread within the Clinical Center. Highly trained Room Bio Decontamination Service (RBDS) engineers and all of the necessary consumables will be required.

Other vendor requirements include:

  • Provide EPA- approved Hydrogen Peroxide Sterillant, floor sealant tape, biological indicators and growth media for the biological indicators.
  • Provide biological indicators: Geobacillus stearothermophilus spores supplied in TYVEK pouched bags used to confirm efficacy of the bio-decontamination.
  • Equipment inside target decontamination area(s) that require separate internal bio-decontamination such as safety cabinets, incubators, freezers, refrigerators, or animal racks AHUs should be reviewed prior to bio-decontamination work is carried out.
  • Vendor will use hydrogen peroxide vapor to bio-deactive microorganisms such as bacteria, viral particle, and fungi.

A minimum of three years’ experience providing decontamination services in the patient care areas of academic medical centers is desired. Experience with decontamination following presence of highly infectious pathogens (e.g., Ebola virus) is preferred.

The Period of Performance is one base year plus four option years. Additional details are available via FBO.gov Solicitation Number: 18-001346

Tags: NIHRequest for Quotes

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC